ABBV trade ideas

Airecap_Hyper Updated 

Buy (Entry Price) above the black line and exit (Stop Loss) below the red line. Can take profit at the suggested Target Price. Entry Price: $148.09 Target Price: $149.49 Stop Loss: $145.76

Airecap_Super Updated 

Short @$147.22 (or Previous High Break Low 15 minutes). TP =$145.27. SP=$148.72

Lextrading

Buffet just released their 13F. The fund dropped all their shares on ABBV and BMY. Both are at the top of the channel. Yellow line is my prediction.

UnknownUnicorn16739272

Joe just recommended ABBV. Great company, way over valued and he would more likely be selling into your buying. Do not follow these fools.

Vladimir6753

Let's vote. I am for selling and buying back on bounces from support levels. ???

The_Position_Trader

We are at all time highs with good volume. Higher prices are likely.

SrjInfinity

Weekly outside bar Holding daily above 21ema Looks like breaking all time high

UnknownUnicorn3614670

We have a weak market and this one is quite holding up! Would want to see this close above 132-133 for long. Close below support - Puts. Im open to any critique. Please feel free to comment and tell me what you think!

Jgooodman Updated 

ABBV potential scalp short, going to let it build a bit more , stay tuned

Rykin_Capital Updated 

Gaining momentum and impulsing. This is good if you are bullish on this one. COVID paranoia is doing wonders for the pharma sector. It is very rare how a whole sector can benefit so much financially from mass hysteria. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are...

zrrsys Updated 

AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories. stop loss is the blue line

trashpanda19

Look for price to eventually reach upper bound resistance $160-165. That would be my exit point.

RocketTickers

ABBV: AbbVie Inc. 2022-01-04 08:15:00 AbbVie Announces U.S. FDA Granted Breakthrough Therapy Designation (BTD) to Telisotuzumab Vedotin (Teliso-V) for Previously Treated Non-Small Cell Lung Cancer

Myantman101

Showing exactly what I look for when I make my trades. Experiences traders know what these indicators mean. Message me if you have any questions about any indicators my arrows are pointing at. With this amount of overlapping signs that point towards a price drop is what leads to my confidence in buying my OTM puts and making high returns. New and veteran...

cloutlesspurity

self explanitory entering calls here. hoping to see 140+

mthompson45

ABBV is a High Yield Growth Stock on the move. ABBV engages in the discovery, development, manufacture, and sale of pharmaceuticals worldwide. The company's offerings include pharmaceutical products such as autoimmune and intestinal disease therapy, HUMIRA, adult plaque psoriasis treatment, SKYRIZI, and adult rheumatoid arthritis treatment, RINVOQ. On December...

UnknownUnicorn3614670

Does the volume and the price look genuine to you? or am I being a paranoid? Disclaimer: I don't have any positions

VishalPatel12

I think ABBV is hitting long time resistance and will complete its 3rd wave near 125.. It will find resistance at ATH and then come down to anywhere between 107 and 113 before completing 4th wave... really like the stock for dividend.